SCYNEXIS, Inc. (SCYX)

USD 0.99

(13.45%)

Total Liabilities Summary of SCYNEXIS, Inc.

  • SCYNEXIS, Inc.'s latest annual total liabilities in 2023 was 55.45 Million USD , down -34.44% from previous year.
  • SCYNEXIS, Inc.'s latest quarterly total liabilities in 2024 Q2 was 47.4 Million USD , up 7.36% from previous quarter.
  • SCYNEXIS, Inc. reported annual total liabilities of 84.57 Million USD in 2022, up 7.63% from previous year.
  • SCYNEXIS, Inc. reported annual total liabilities of 78.57 Million USD in 2021, down -1.5% from previous year.
  • SCYNEXIS, Inc. reported quarterly total liabilities of 47.4 Million USD for 2024 Q2, up 7.36% from previous quarter.
  • SCYNEXIS, Inc. reported quarterly total liabilities of 61.77 Million USD for 2023 Q2, down -38.35% from previous quarter.

Annual Total Liabilities Chart of SCYNEXIS, Inc. (2023 - 2012)

Historical Annual Total Liabilities of SCYNEXIS, Inc. (2023 - 2012)

Year Total Liabilities Total Liabilities Growth
2023 55.45 Million USD -34.44%
2022 84.57 Million USD 7.63%
2021 78.57 Million USD -1.5%
2020 79.77 Million USD 80.26%
2019 44.25 Million USD 101.68%
2018 21.94 Million USD -10.21%
2017 24.44 Million USD -2.13%
2016 24.97 Million USD 240.97%
2015 7.32 Million USD 17.35%
2014 6.24 Million USD -70.48%
2013 21.13 Million USD -32.78%
2012 31.44 Million USD 0.0%

Peer Total Liabilities Comparison of SCYNEXIS, Inc.

Name Total Liabilities Total Liabilities Difference
Collegium Pharmaceutical, Inc. 947.87 Million USD 94.15%
Embecta Corp. 2.03 Billion USD 97.277%
ANI Pharmaceuticals, Inc. 471.67 Million USD 88.244%
Dynavax Technologies Corporation 375.02 Million USD 85.214%
Esperion Therapeutics, Inc. 660.79 Million USD 91.609%
Pacira BioSciences, Inc. 704.25 Million USD 92.126%
PainReform Ltd. 2.69 Million USD -1960.572%
Aquestive Therapeutics, Inc. 163.9 Million USD 66.169%
Sunshine Biopharma, Inc. 6.13 Million USD -803.153%
China SXT Pharmaceuticals, Inc. 9.19 Million USD -502.939%
Cosmos Health Inc. 30.25 Million USD -83.29%
Journey Medical Corporation 56.49 Million USD 1.857%
Sunshine Biopharma, Inc. 6.13 Million USD -803.153%
Safety Shot Inc 3.89 Million USD -1324.701%
Alpha Teknova, Inc. 38.55 Million USD -43.835%
Intra-Cellular Therapies, Inc. 136.87 Million USD 59.487%
Bright Green Corporation 6.43 Million USD -761.279%
Procaps Group, S.A. 462.06 Million USD 88.0%
Theratechnologies Inc. 98.63 Million USD 43.785%
Harrow Health, Inc. 241.75 Million USD 77.063%
Sonoma Pharmaceuticals, Inc. 8.75 Million USD -533.28%
Biofrontera Inc. 23.13 Million USD -139.639%
DURECT Corporation 30.4 Million USD -82.365%
Supernus Pharmaceuticals, Inc. 487.46 Million USD 88.625%
Cronos Group Inc. 43.73 Million USD -26.783%
OptiNose, Inc. 194.33 Million USD 71.467%
Ironwood Pharmaceuticals, Inc. 817.36 Million USD 93.216%
Kala Pharmaceuticals, Inc. 48.44 Million USD -14.46%
RedHill Biopharma Ltd. 20.97 Million USD -164.323%
Organogenesis Holdings Inc. 181.36 Million USD 69.426%
Guardion Health Sciences, Inc. 3.77 Million USD -1369.99%
Cumberland Pharmaceuticals Inc. 52.51 Million USD -5.586%
Radius Health, Inc. 804.29 Million USD 93.106%
Universe Pharmaceuticals INC 13.75 Million USD -303.146%
ProPhase Labs, Inc. 42.54 Million USD -30.336%
Phibro Animal Health Corporation 725.54 Million USD 92.357%
Procaps Group S.A. 462.06 Million USD 88.0%
Alvotech 1.88 Billion USD 97.055%
TherapeuticsMD, Inc. 14.02 Million USD -295.45%
Viatris Inc. 27.21 Billion USD 99.796%
Rockwell Medical, Inc. 30.88 Million USD -79.554%
Aytu BioPharma, Inc. 90.37 Million USD 38.647%
SIGA Technologies, Inc. 57.97 Million USD 4.359%
Tilray Brands, Inc. 892.11 Million USD 93.784%
Lifecore Biomedical, Inc. 219.8 Million USD 74.773%
Shineco, Inc. 47.6 Million USD -16.487%
PetIQ, Inc. 645.22 Million USD 91.406%
Regencell Bioscience Holdings Limited 219.51 Thousand USD -25160.578%
Incannex Healthcare Limited 5.83 Million USD -851.115%
Neurocrine Biosciences, Inc. 1.01 Billion USD 94.561%
Alimera Sciences, Inc. 107.35 Million USD 48.348%
Silver Spike Investment Corp. 3 Million USD -1742.296%
Assertio Holdings, Inc. 148.41 Million USD 62.639%
Shuttle Pharmaceuticals Holdings, Inc. 1.89 Million USD -2824.632%
Petros Pharmaceuticals, Inc. 21.31 Million USD -160.136%
Clever Leaves Holdings Inc. 7.02 Million USD -689.212%
Cyclo Therapeutics, Inc. 8.49 Million USD -553.08%
Avadel Pharmaceuticals plc 173.38 Million USD 68.02%
Hempacco Co., Inc. 18.82 Million USD -194.596%
Talphera, Inc. 6.29 Million USD -781.558%
Alvotech 1.88 Billion USD 97.055%
Eagle Pharmaceuticals, Inc. 172.6 Million USD 67.874%
Lantheus Holdings, Inc. 835.25 Million USD 93.361%
Currenc Group, Inc. 177.67 Million USD 68.791%
Kamada Ltd. 109.96 Million USD 49.576%
Indivior PLC 1.95 Billion USD 97.158%
Evoke Pharma, Inc. 9.64 Million USD -474.726%
Flora Growth Corp. 17.22 Million USD -221.972%
Cyclo Therapeutics, Inc. 8.49 Million USD -553.08%
Evolus, Inc. 209.68 Million USD 73.556%
HUTCHMED (China) Limited 536.38 Million USD 89.662%
Amphastar Pharmaceuticals, Inc. 873.49 Million USD 93.652%
Akanda Corp. 12.66 Million USD -337.687%